Immulogic Pharmaceutical Corp Watch

from 10-K405 1 page Letter Agreement Dated 7/30/1999

from 10-K405 ~5 pages Amendment of the Office Lease - 11/13/1991

from 10-K405 ~5 pages First Amendment to License Agreement 6/16/1998

from 10-Q ~20 pages Clinical Supply & Process Validation Agreement

from 10-Q ~20 pages License Agreement

from 10-K405 ~10 pages Sublease Dated January 29, 1998

from 10-Q ~5 pages Consulting Agreement Dated May 13, 1997

from 10-K 1 page Letter Agreement

from 10-K ~10 pages Consultation Agreement

from 10-K 1 page Amendment No.1 to Rights Agreement

from 10-K ~5 pages Agreement Dated 10-25/96

from 10-K ~10 pages Severance & Settlement Agreement 3/4/97

from 10-K ~5 pages Severance & Settlement Agreement 12/4/96

from 10-Q 1 page <page> 1 Immulogic Pharmaceutical Corporation Amendment to the 1993 Director Stock Option Plan Adopted by the Board of Directors on March 21, 1996 Approved by the Stockholders on May 26, 1996 Resolved: That, Subject to Stockholder Approval, the 1993 Director Stock - Option Plan Be and Hereby Is Amended by Deleting Section 4(a) and Adding a New Section 4(a) to Read in Its Entirety as Follows: "(A) the Maximum Number of Shares Which May Be Issued Under the Plan Shall Be 300,000 Shares of the Company's Common Stock, Par Value $.01 Per Share (The "Common Stock"), Subject to Adjustment as Provided in Section 9 of the Plan."

from 10-Q ~5 pages Consulting Agreement